11 results on '"Brak, Ivan V."'
Search Results
2. White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group
- Author
-
van Velzen, Laura S., Kelly, Sinead, Isaev, Dmitry, Aleman, Andre, Aftanas, Lyubomir I., Bauer, Jochen, Baune, Bernhard T., Brak, Ivan V., Carballedo, Angela, Connolly, Colm G., Couvy-Duchesne, Baptiste, Cullen, Kathryn R., Danilenko, Konstantin V., Dannlowski, Udo, Enneking, Verena, Filimonova, Elena, Förster, Katharina, Frodl, Thomas, Gotlib, Ian H., Groenewold, Nynke A., Grotegerd, Dominik, Harris, Mathew A., Hatton, Sean N., Hawkins, Emma L., Hickie, Ian B., Ho, Tiffany C., Jansen, Andreas, Kircher, Tilo, Klimes-Dougan, Bonnie, Kochunov, Peter, Krug, Axel, Lagopoulos, Jim, Lee, Renick, Lett, Tristram A., Li, Meng, MacMaster, Frank P., Martin, Nicholas G., McIntosh, Andrew M., McLellan, Quinn, Meinert, Susanne, Nenadić, Igor, Osipov, Evgeny, Penninx, Brenda W. J. H., Portella, Maria J., Repple, Jonathan, Roos, Annerine, Sacchet, Matthew D., Sämann, Philipp G., Schnell, Knut, Shen, Xueyi, Sim, Kang, Stein, Dan J., van Tol, Marie-Jose, Tomyshev, Alexander S., Tozzi, Leonardo, Veer, Ilya M., Vermeiren, Robert, Vives-Gilabert, Yolanda, Walter, Henrik, Walter, Martin, van der Wee, Nic J. A., van der Werff, Steven J. A., Schreiner, Melinda Westlund, Whalley, Heather C., Wright, Margaret J., Yang, Tony T., Zhu, Alyssa, Veltman, Dick J., Thompson, Paul M., Jahanshad, Neda, and Schmaal, Lianne
- Published
- 2020
- Full Text
- View/download PDF
3. Task-positive and task-negative networks in major depressive disorder: A combined fMRI and EEG study
- Author
-
Knyazev, Gennady G., Savostyanov, Alexander N., Bocharov, Andrey V., Brak, Ivan V., Osipov, Evgeny A., Filimonova, Elena A., Saprigyn, Alexander E., and Aftanas, Lyubomir I.
- Published
- 2018
- Full Text
- View/download PDF
4. Correction: Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders
- Author
-
Opel, Nils, Thalamuthu, Anbupalam, Milaneschi, Yuri, Grotegerd, Dominik, Flint, Claas, Leenings, Ramona, Goltermann, Janik, Richter, Maike, Hahn, Tim, Woditsch, Georg, Berger, Klaus, Hermesdorf, Marco, McIntosh, Andrew, Whalley, Heather C., Harris, Mathew A., MacMaster, Frank P., Walter, Henrik, Veer, Ilya M., Frodl, Thomas, Carballedo, Angela, Krug, Axel, Nenadic, Igor, Kircher, Tilo, Aleman, Andre, Groenewold, Nynke A., Stein, Dan J., Soares, Jair C., Zunta-Soares, Giovana B., Mwangi, Benson, Wu, Mon-Ju, Walter, Martin, Li, Meng, Harrison, Ben J., Davey, Christopher G., Cullen, Kathryn R., Klimes-Dougan, Bonnie, Mueller, Bryon A., Sämann, Philipp G., Penninx, Brenda, Nawijn, Laura, Veltman, Dick J., Aftanas, Lyubomir, Brak, Ivan V., Filimonova, Elena A., Osipov, Evgeniy A., Reneman, Liesbeth, Schrantee, Anouk, Grabe, Hans J., Van der Auwera, Sandra, Wittfeld, Katharina, Hosten, Norbert, Völzke, Henry, Sim, Kang, Gotlib, Ian H., Sacchet, Matthew D., Lagopoulos, Jim, Hatton, Sean N., Hickie, Ian, Pozzi, Elena, Thompson, Paul M., Jahanshad, Neda, Schmaal, Lianne, Baune, Bernhard T., and Dannlowski, Udo
- Published
- 2021
- Full Text
- View/download PDF
5. Transcranial Current Stimulation as a Tool of Neuromodulation of Cognitive Functions in Parkinson’s Disease
- Author
-
Brak, Ivan V., primary, Filimonova, Elena, additional, Zakhariya, Oleg, additional, Khasanov, Rustam, additional, and Stepanyan, Ivan, additional
- Published
- 2022
- Full Text
- View/download PDF
6. Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders
- Author
-
Opel, Nils, Thalamuthu, Anbupalam, Milaneschi, Yuri, Grotegerd, Dominik, Flint, Claas, Leenings, Ramona, Goltermann, Janik, Richter, Maike, Hahn, Tim, Woditsch, Georg, Berger, Klaus, Hermesdorf, Marco, McIntosh, Andrew, Whalley, Heather C., Harris, Mathew A., MacMaster, Frank P., Walter, Henrik, Veer, Ilya M., Frodl, Thomas, Carballedo, Angela, Krug, Axel, Nenadic, Igor, Kircher, Tilo, Aleman, Andre, Groenewold, Nynke A., Stein, Dan J., Soares, Jair C., Zunta-Soares, Giovana B., Mwangi, Benson, Wu, Mon-Ju, Walter, Martin, Li, Meng, Harrison, Ben J., Davey, Christopher G., Cullen, Kathryn R., Klimes-Dougan, Bonnie, Mueller, Bryon A., Sämann, Philipp G., Penninx, Brenda, Nawijn, Laura, Veltman, Dick J., Aftanas, Lyubomir, Brak, Ivan V., Filimonova, Elena A., Osipov, Evgeniy A., Reneman, Liesbeth, Schrantee, Anouk, Grabe, Hans J., Van der Auwera, Sandra, Wittfeld, Katharina, Hosten, Norbert, Völzke, Henry, Sim, Kang, Gotlib, Ian H., Sacchet, Matthew D., Lagopoulos, Jim, Hatton, Sean N., Hickie, Ian, Pozzi, Elena, Thompson, Paul M., Jahanshad, Neda, Schmaal, Lianne, Baune, Bernhard T., and Dannlowski, Udo
- Subjects
Depression ,Diagnostic markers ,Article - Abstract
Emerging evidence suggests that obesity impacts brain physiology at multiple levels. Here we aimed to clarify the relationship between obesity and brain structure using structural MRI (n = 6420) and genetic data (n = 3907) from the ENIGMA Major Depressive Disorder (MDD) working group. Obesity (BMI > 30) was significantly associated with cortical and subcortical abnormalities in both mass-univariate and multivariate pattern recognition analyses independent of MDD diagnosis. The most pronounced effects were found for associations between obesity and lower temporo-frontal cortical thickness (maximum Cohen´s d (left fusiform gyrus) = −0.33). The observed regional distribution and effect size of cortical thickness reductions in obesity revealed considerable similarities with corresponding patterns of lower cortical thickness in previously published studies of neuropsychiatric disorders. A higher polygenic risk score for obesity significantly correlated with lower occipital surface area. In addition, a significant age-by-obesity interaction on cortical thickness emerged driven by lower thickness in older participants. Our findings suggest a neurobiological interaction between obesity and brain structure under physiological and pathological brain conditions.
- Published
- 2020
7. The influence of repeated administration of poloxamer 407 on serum lipoproteins and protease activity in mouse liver and heart
- Author
-
Korolenko, Tatyana A., Tuzikov, Fedor V., Johnston, Thomas P., Tuzikova, Natalia A., Kisarova, Yana A., Zhanaeva, Svetlana Ya., Alexeenko, Tatyana V., Zhukova, Natalia A., Brak, Ivan V., Spiridonov, Victor K., Filjushina, Elena E., Cherkanova, Marina S., and Monoszon, Anna A.
- Subjects
Physiological aspects ,Dosage and administration ,Macrophages -- Physiological aspects ,Poloxamers -- Physiological aspects -- Dosage and administration ,Lipoproteins -- Physiological aspects ,Proteases -- Physiological aspects ,Heart -- Physiological aspects ,Liver -- Physiological aspects ,Blood lipoproteins -- Physiological aspects ,Proteolipids -- Physiological aspects - Abstract
Introduction Recently, using a novel small-angle X-ray scattering (SAXS) method for the determination of fractional and subfractional composition of lipoproteins (LPs), we showed that a high dose of atorvastatin exerts [...], The effects of repeated administration of poloxamer 407 (P-407) on lipoprotein-cholesterol (LP-C) and lipoprotein-triglyceride (LP-TG) fractions and subtractions, as well as the effect on liver and heart proteases, were studied. Repeated administration of P-407 to male CBA mice resulted in a model of atherosclerosis with increased diastolic blood pressure; there was a drastic increase in total serum cholesterol and especially TG. A novel small-angle X-ray scattering method for the determination of the fractional and subfractional composition of LP-C and LP-TG was used. In chronically P-107-treated mice, P-107 significantly increased atherogenic low-density lipoprotein C (LDL-C) fractions, as well as intermediate-density lipoprotein C (IDL-C), and [LDL.sub.1-3]-C subfractions, and very-low-density lipoprotein-C (VLDL-C) fractions, as well as [VLDL.sub.1-2-C] and [VLDL.sub.3-5]-C subfractions), to a lesser extent, the total anti-atherogenic high-density lipoprotein C (HDL-C) fraction, as well as [HDL.sub.2]-C and [HDL.sub.3]-C subfractions. Additionally, we demonstrated an increase in the serum chitotriosidase activity, without significant changes in serum matrix metalloprotease (MMP) activity. Morphological changes observed in P-407-treated mice included atherosclerosis in the heart and storage syndrome in the liver macrophages. P-407 significantly increased the activity of cysteine, aspartate proteases, and MMPs in the heart, and only the activity of cathepsin B and MMPs in the liver of mice. Thus, repeated administration of P4-07 to mice induced atherosclerosis secondary to sustained dyslipidemia and formation of foamy macrophages in liver, and also modulated the activity of heart and liver proteases. Key words: lipoprotein fractions and subfractions, P-407-induced heart and liver injury, cathepsins B, L, and D, matrix metalloproteases, chitotriosidase. L'effet d'une administration repetee de poloxamer 407 (P-407) sur les fractions et les sous-fractions de lipoproteines-cholesterol (LP-C) et de lipoproteines-triglycerides (LP-TG) ainsi que son effet sur les proteases du foie et du coeur ont ete etudies. L'administration repetee de P-107 chez les souris produisait un modele d'atherosclerose caracterise par une pression sanguine diastolique accrue ; on observait une augmentation radicale du cholesterol total serique et particulierement des TG. Une nouvelle methode de dispersion de rayons-X a angle reduit a ete utilisee pour determiner la composition des fractions et des sous-fractions de LP-C et LP-TG. Lorsqu'administre de facon chronique a des souris, le P-107 augmentait significativement les lipoproteines de faible densite C (LDL-C) atherogenes (sous-fractions lipoproteines de densite intermediaire (IDL-C et [LDL.sub.1-3]-C) et les lipoproteines de tres faible densite-C (VLDL-C) (sous-fractions [VLDL.sub.1-2]-C et [VLDL.sub.3-5]-C) et, dans une moindre mesure, la fraction totale anti-atherogene des lipoproteines de haute densite (HDL-C: sous fractions [HDL.sub.2]-C et [HDL.sub.3]-C). De plus, une augmentation de Factivite chitotriosidase serique etait demontree, alors que l'activite metalloprotease de la matrice (MMP) du serum ne changeait pas significativement. Les changements morphologiques observes chez les souris traitees au P-407 incluaient l'atherosclerose du coeur et le syndrome de stockage des macrophages du foie. Le P4-07 augmentait significativement Factivite des proteases a cysteine, des proteases a aspartate et des MMP dans le coeur, et Factivite de la cathepsine B et des MMP seulement, dans le foie des souris. Ainsi, l'administration repetee de P-407 chez les souris induisait une atherosclerose secondaire a une dyslipemie prolongee et a la formation de macrophages spumeux dans le foie, ainsi qu'une modulation de l'activite des proteases du cour et du foie. Mots-cles : fractions et sous-fractions de lipoproteines, dommage cardiaque et hepatique induit par le P-407, cathepsines B, L et D, metalloproteases de la matrice, chitotriosidase. [Traduit par la Redaction]
- Published
- 2012
- Full Text
- View/download PDF
8. White matter disturbances in major depressive disorder : a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group
- Author
-
van Velzen, Laura S., Kelly, Sinead, Isaev, Dmitry, Aleman, Andre, Aftanas, Lyubomir I., Bauer, Jochen, Baune, Bernhard T., Brak, Ivan V., Carballedo, Angela, Connolly, Colm G., Couvy-Duchesne, Baptiste, Cullen, Kathryn R., Danilenko, Konstantin V., Dannlowski, Udo, Enneking, Verena, Filimonova, Elena, Förster, Katharina, Frodl, Thomas, Gotlib, Ian H., Groenewold, Nynke A., Grotegerd, Dominik, Harris, Mathew A., Hatton, Sean N., Hawkins, Emma L., Hickie, Ian B., Ho, Tiffany C., Jansen, Andreas, Kircher, Tilo, Klimes-Dougan, Bonnie, Kochunov, Peter, Krug, Axel, Lagopoulos, Jim, Lee, Renick, Lett, Tristram A., Li, Meng, MacMaster, Frank P., Martin, Nicholas G., McIntosh, Andrew M., McLellan, Quinn, Meinert, Susanne, Nenadić, Igor, Osipov, Evgeny, Penninx, Brenda W. J. H., Portella, Maria J., Repple, Jonathan, Roos, Annerine, Sacchet, Matthew D., Sämann, Philipp G., Schnell, Knut, Shen, Xueyi, Sim, Kang, Stein, Dan J., van Tol, Marie-Jose, Tomyshev, Alexander S., Tozzi, Leonardo, Veer, Ilya M., Vermeiren, Robert, Vives-Gilabert, Yolanda, Walter, Henrik, Walter, Martin, van der Wee, Nic J. A., van der Werff, Steven J. A., Schreiner, Melinda Westlund, Whalley, Heather C., Wright, Margaret J., Yang, Tony T., Zhu, Alyssa, Veltman, Dick J., Thompson, Paul M., Jahanshad, Neda, Schmaal, Lianne, and Universitat Autònoma de Barcelona
- Subjects
Depression ,Neuroscience - Abstract
Altres ajuts: The ENIGMA-Major Depressive Disorder working group gratefully acknowledges support from the NIH Big Data to Knowledge (BD2K) award (U54 EB020403 to PMT) and NIH grant R01 MH116147 (PMT). LS is supported by an NHMRC MRFF Career Development Fellowship (APP1140764). We wish to acknowledge the patients and control subjects that have particiaped int the study. We thank Rosa Schirmer, Elke Schreiter, Reinhold Borschke and Ines Eidner for image acquisition and data preparation, and Anna Oliynyk for quality checks. We thank Dorothee P. Auer and F. Holsboer for initiation of the RUD study. We wish to acknowledge the patients and control subjects that have particiaped int the study. We thank Rosa Schirmer, Elke Schreiter, Reinhold Borschke and Ines Eidner for image acquisition and data preparation, and Anna Oliynyk for quality checks. We thank Dorothee P. Auer and F. Holsboer for initiation of the RUD study. NESDA: The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen) and mental health care organizations, see www.nesda.nl. M-JvT was supported by a VENI grant (NWO grant number 016.156.077). UCSF: This work was supported by the Brain and Behavior Research Foundation (formerly NARSAD) to TTY; the National Institute of Mental Health (R01MH085734 to TTY; K01MH117442 to TCH) and by the American Foundation for Suicide Prevention (PDF-1-064-13) to TCH. Stanford: This work was supported by NIMH Grants R01MH59259 and R37101495 to IHG. MS is partially supported by an award funded by the Phyllis and Jerome Lyle Rappaport Foundation. Muenster: This work was funded by the German Research Foundation (SFB-TRR58, Projects C09 and Z02 to UD) and the Interdisciplinary Center for Clinical Research (IZKF) of the medical faculty of Münster (grant Dan3/012/17 to UD). Marburg: This work was funded by the German Research Foundation (DFG, grant FOR2107 DA1151/5-1 and DA1151/5-2 to UD; KI 588/ 14-1, KI 588/14-2 to TK; KR 3822/7-1, KR 3822/7-2 to AK; JA 1890/ 7-1, JA 1890/7-2 to AJ). IMH-MDD: This work was supported by the National Healthcare Group Research Grant (SIG/15012) awarded to KS. Barcelona: This study was funded by two grants of the Fondo de Investigación Sanitaria from the Instituto de Salud Carlos III, by the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM). The author is funded through 'Miguel Servet' research contract (CP16-0020), co-financed by the European Regional Development Fund (ERDF) (2016-2019). QTIM: We thank the twins and singleton siblings who gave generously of their time to participate in the QTIM study. We also thank the many research assistants, radiographers, and IT support staff for data acquisition and DNA sample preparation. This study was funded by White matter disturbances in major depressive disorder: a coordinated analysis across 20 international. . . 1521 the National Institute of Child Health & Human Development (RO1 HD050735); National Institute of Biomedical Imaging and Bioengineering (Award 1U54EB020403-01, Subaward 56929223); National Health and Medical Research Council, Australia (Project Grants 496682, 1009064). NIH ENIGMA-BD2K U54 EB020403 (Thompson); R01 MH117601 (Jahanshad/Schmaal). Magdeburg: M.L. and M.W. are funded by SFB 779. Bipolar Family Study: This study has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013). This paper reflects only the author's views and the European Union is not liable for any use that may be made of the information contained therein. This work was also supported by a Wellcome Trust Strategic Award (104036/Z/14/Z). Minnesota Adolescent Depression Study: The study was funded by the National Institute of Mental Health (K23MH090421), the National Alliance for Research on Schizophrenia and Depression, the University of Minnesota Graduate School, the Minnesota Medical Foundation, and the Biotechnology Research Center (P41 RR008079 to the Center for Magnetic Resonance Research), University of Minnesota, and the Deborah E. Powell Center for Women's Health Seed Grant, University of Minnesota. Dublin: This study was supported by Science Foundation Ireland through a Stokes Professorhip grant to TF. MPIP: The MPIP Sample comprises patients included in the Recurrent Unipolar Depression (RUD) Case-Control study at the clinic of the Max Planck Institute of Psychiatry, Munich, German. The RUD study was supported by GlaxoSmithKline. Alterations in white matter (WM) microstructure have been implicated in the pathophysiology of major depressive disorder (MDD). However, previous findings have been inconsistent, partially due to low statistical power and the heterogeneity of depression. In the largest multi-site study to date, we examined WM anisotropy and diffusivity in 1305 MDD patients and 1602 healthy controls (age range 12-88 years) from 20 samples worldwide, which included both adults and adolescents, within the MDD Working Group of the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) consortium. Processing of diffusion tensor imaging (DTI) data and statistical analyses were harmonized across sites and effects were meta-analyzed across studies. We observed subtle, but widespread, lower fractional anisotropy (FA) in adult MDD patients compared with controls in 16 out of 25 WM tracts of interest (Cohen's d between 0.12 and 0.26). The largest differences were observed in the corpus callosum and corona radiata. Widespread higher radial diffusivity (RD) was also observed (all Cohen's d between 0.12 and 0.18). Findings appeared to be driven by patients with recurrent MDD and an adult age of onset of depression. White matter microstructural differences in a smaller sample of adolescent MDD patients and controls did not survive correction for multiple testing. In this coordinated and harmonized multisite DTI study, we showed subtle, but widespread differences in WM microstructure in adult MDD, which may suggest structural disconnectivity in MDD.
- Published
- 2019
9. White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group
- Author
-
van Velzen, Laura S., primary, Kelly, Sinead, additional, Isaev, Dmitry, additional, Aleman, Andre, additional, Aftanas, Lyubomir I., additional, Bauer, Jochen, additional, Baune, Bernhard T., additional, Brak, Ivan V., additional, Carballedo, Angela, additional, Connolly, Colm G., additional, Couvy-Duchesne, Baptiste, additional, Cullen, Kathryn R., additional, Danilenko, Konstantin V., additional, Dannlowski, Udo, additional, Enneking, Verena, additional, Filimonova, Elena, additional, Förster, Katharina, additional, Frodl, Thomas, additional, Gotlib, Ian H., additional, Groenewold, Nynke A., additional, Grotegerd, Dominik, additional, Harris, Mathew A., additional, Hatton, Sean N., additional, Hawkins, Emma L., additional, Hickie, Ian B., additional, Ho, Tiffany C., additional, Jansen, Andreas, additional, Kircher, Tilo, additional, Klimes-Dougan, Bonnie, additional, Kochunov, Peter, additional, Krug, Axel, additional, Lagopoulos, Jim, additional, Lee, Renick, additional, Lett, Tristram A., additional, Li, Meng, additional, MacMaster, Frank P., additional, Martin, Nicholas G., additional, McIntosh, Andrew M., additional, McLellan, Quinn, additional, Meinert, Susanne, additional, Nenadić, Igor, additional, Osipov, Evgeny, additional, Penninx, Brenda W. J. H., additional, Portella, Maria J., additional, Repple, Jonathan, additional, Roos, Annerine, additional, Sacchet, Matthew D., additional, Sämann, Philipp G., additional, Schnell, Knut, additional, Shen, Xueyi, additional, Sim, Kang, additional, Stein, Dan J., additional, van Tol, Marie-Jose, additional, Tomyshev, Alexander S., additional, Tozzi, Leonardo, additional, Veer, Ilya M., additional, Vermeiren, Robert, additional, Vives-Gilabert, Yolanda, additional, Walter, Henrik, additional, Walter, Martin, additional, van der Wee, Nic J. A., additional, van der Werff, Steven J. A., additional, Schreiner, Melinda Westlund, additional, Whalley, Heather C., additional, Wright, Margaret J., additional, Yang, Tony T., additional, Zhu, Alyssa, additional, Veltman, Dick J., additional, Thompson, Paul M., additional, Jahanshad, Neda, additional, and Schmaal, Lianne, additional
- Published
- 2019
- Full Text
- View/download PDF
10. Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer
- Author
-
Gashenko, Elena A., primary, Lebedeva, Valentina A., additional, Brak, Ivan V., additional, Tsykalenko, Elena A., additional, Vinokurova, Galina V., additional, and Korolenko, Tatyana A., additional
- Published
- 2013
- Full Text
- View/download PDF
11. Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer.
- Author
-
Gashenko, Elena A., Lebedeva, Valentina A., Brak, Ivan V., Tsykalenko, Elena A., Vinokurova, Galina V., and Korolenko, Tatyana A.
- Subjects
- *
OVARIAN cancer , *CARCINOGENS , *ONCOLOGY , *BIOMARKERS , *BLOOD plasma - Abstract
Objectives. To evaluate procathepsin B, as well as endogenous inhibitors of cysteine proteases (cystatin B and cystatin C) in biological fluids as possible biomarkers of ovarian cancer. To observe levels of serum procathepsin B in different age groups. Study design. The sample (N=27) of women with gynaecological tumours included 18 patients with ovarian cancer (n=18) and 9 patients with benign ovarian tumours (n=9); 72 healthy women were in the control group. All patients were treated in Novosibirsk Regional Oncological Center, Russia. Serum samples of healthy women (n=40) aged 18-70 years were used as controls for common biomarker of ovarian cancer CA- 125. In the Procathepsin B study, serum samples of healthy women (n=32) aged 18-40 years (n=14), 41-55 years (n=10) and 56-80 (n=8) years were used as controls. Methods. Common biomarker of ovarian cancer, CA-125, was assayed by using a commercial kit (Vector, Koltsovo, Novosibirsk Region, Russia). Procathepsin B was measured by means of a commercial kit for human procathepsin B (R&D, USA); cystatin C was measured by commercial ELISA kits for human (BioVendor, Czechia); cystatin B was measured by ELISA kits for human (USCN Life Science Inc., Wuhan, China). Statistical analysis was performed by one-way ANOVA (Statistica 10 Program). Results. In the control group, serum procathepsin B concentration did not reveal age dependency. In the ovarian cancer group, both levels of serum procathepsin B and standard biomarker CA-125 increased significantly (both p<0.001) compared with the control group. In the benign ovarian tumour group, serum procathepsin B (p<0.001) and CA-125 (p=0.004) increased about 2.5- and 8-fold compared to the control group. Serum cystatin B level increased up to 1.7-fold in the ovarian cancer group compared to the control group. The increase of serum CA-125 was about 3.5-fold higher (p=0.017) and procathepsin B was 1.8-fold higher (p<0.05) in the ovarian cancer group compared to the benign tumour group. Cystatin B in ascites fluid increased equally in both ovarian cancer (p<0.001) and benign ovarian tumours group (p<0.05). Cystatin C concentration in ascites fluid increased only in patients with ovarian cancer (p<0.05) and did not change in the benign tumours group. Large increases of procathepsin B level (about 13-fold, p<0.001) and to a lesser degree of cystatin C (1.8-fold, p<0.05) and cystatin B levels (1.4 fold, p<0.001) were revealed in ascites fluids of patients with ovarian cancer compared to the control serum. The significant difference in serum procathepsin B levels was noted between the ovarian cancer and benign tumour groups (p<0.05), which could be used in differential diagnostics between malignant and benign gynaecological tumours. Conclusion. Serum procathepsin B demonstrated significant promise as a new biomarker of ovarian cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.